Analysis of EPA® (a Food Intake Assessment Tool) as a Screening Test for Malnutrition in General Medicine

Malnutrition Clinical Trial

— GEN-EPA  

Official title:

Analysis of EPA® (a Food Intake Assessment Tool) as a Screening Test for Malnutrition in General Medicine

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03555461
• Other study ID #: 35RC17_3087-GEN-EPA
• Status: Completed
• Start date: January 22, 2018
• Est. completion date: April 13, 2018

Study information

• Verified date: May 2018
• Source: Rennes University Hospital
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The main objective is to evaluate the sensitivity of the EPA® for screening for malnutrition in general medicine in adults.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 563
• Est. completion date: April 13, 2018
• Est. primary completion date: April 13, 2018
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• To be an adult,

• Consulting the principal investigator, a general practitioner in his activity of substitute doctor,

• During the inclusion period,

• Not opposed to participating in the study.

Exclusion Criteria:

• Patients benefiting from artificial nutrition,

• Patients with advanced dementia,

• Pregnant or postpartum women,

• Patients who do not understand or speak French,

• Patients treated with diuretics who have had a change in treatment dosage during the last 6 months,

• Patients for whom weight measurement is not possible in the office (wheelchair, disability ...),

• Patients who have already been included once,

• Patients who have had surgery for obesity,

• Major persons subject to legal protection (legal safeguards, guardianship, tutorship), persons deprived of their liberty, ...

Related Conditions & MeSH terms

• Malnutrition

Locations

Country	Name	City	State
France	Cabinet médical des Rosiers	Acigné
France	Cabinet médical des Docteurs Le Vagueres et Godard,	Berné
France	Cabinet médical du Dr Berthier,	Languidic

Sponsors (1)

Lead Sponsor	Collaborator
Rennes University Hospital

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	presence or absence of malnutrition	presence or absence of malnutrition based on BMI and / or percentage of weight loss	The inclusion day
Primary	Score EPA	score obtained with the EPA® tool (assessment of food intake)	The inclusion day